These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Too much of a good thing: a review of primary immune regulatory disorders. Tsilifis C; Slatter MA; Gennery AR Front Immunol; 2023; 14():1279201. PubMed ID: 38022498 [TBL] [Abstract][Full Text] [Related]
4. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM Front Immunol; 2021; 12():671755. PubMed ID: 34447369 [TBL] [Abstract][Full Text] [Related]
5. Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review. Jamee M; Moniri S; Zaki-Dizaji M; Olbrich P; Yazdani R; Jadidi-Niaragh F; Aghamahdi F; Abolhassani H; Condliffe AM; Aghamohammadi A; Azizi G Clin Rev Allergy Immunol; 2020 Dec; 59(3):323-333. PubMed ID: 31111319 [TBL] [Abstract][Full Text] [Related]
6. Current and Future Therapeutic Approaches for Thymic Stromal Cell Defects. Kreins AY; Bonfanti P; Davies EG Front Immunol; 2021; 12():655354. PubMed ID: 33815417 [TBL] [Abstract][Full Text] [Related]
7. Primary immunodeficiency and autoimmunity: A comprehensive review. Amaya-Uribe L; Rojas M; Azizi G; Anaya JM; Gershwin ME J Autoimmun; 2019 May; 99():52-72. PubMed ID: 30795880 [TBL] [Abstract][Full Text] [Related]
8. Infection and autoinflammation in inborn errors of immunity: brothers in arms. Delafontaine S; Meyts I Curr Opin Immunol; 2021 Oct; 72():331-339. PubMed ID: 34543865 [TBL] [Abstract][Full Text] [Related]
11. Precision medicine in the treatment of primary immunodeficiency diseases. Leiding JW; Ballow M Curr Opin Allergy Clin Immunol; 2018 Apr; 18(2):159-166. PubMed ID: 29406361 [TBL] [Abstract][Full Text] [Related]
12. Reversion Mosaicism in Primary Immunodeficiency Diseases. Miyazawa H; Wada T Front Immunol; 2021; 12():783022. PubMed ID: 34868061 [TBL] [Abstract][Full Text] [Related]
13. Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs). Seidel MG Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):673-679. PubMed ID: 33275670 [TBL] [Abstract][Full Text] [Related]
14. Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune Dysregulation. Ballow M; Leiding JW Clin Rev Allergy Immunol; 2022 Aug; 63(1):1-8. PubMed ID: 34169440 [TBL] [Abstract][Full Text] [Related]
15. Persistent Activation of Innate Immunity in Patients with Primary Antibody Deficiencies. Tsinti G; Makris D; Germenis AE; Speletas M J Immunol Res; 2020; 2020():8317671. PubMed ID: 33274244 [TBL] [Abstract][Full Text] [Related]
16. Immunological Features of Neuroblastoma Amplified Sequence Deficiency: Report of the First Case Identified Through Newborn Screening for Primary Immunodeficiency and Review of the Literature. Ricci S; Lodi L; Serranti D; Moroni M; Belli G; Mancano G; La Barbera A; Forzano G; Mangone G; Indolfi G; Azzari C Front Immunol; 2019; 10():1955. PubMed ID: 31507590 [TBL] [Abstract][Full Text] [Related]
17. RAC2 and primary human immune deficiencies. Lougaris V; Baronio M; Gazzurelli L; Benvenuto A; Plebani A J Leukoc Biol; 2020 Aug; 108(2):687-696. PubMed ID: 32542921 [TBL] [Abstract][Full Text] [Related]